Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma

A. Sahal, J. Das, A. Mansur (Birmingham, United Kingdom)

Source: Annual Congress 2013 –Asthma
Session: Asthma
Session type: Thematic Poster Session
Number: 857
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sahal, J. Das, A. Mansur (Birmingham, United Kingdom). Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma. Eur Respir J 2013; 42: Suppl. 57, 857

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016

Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study
Source: Eur Respir J, 52 (2) 1800616; 10.1183/13993003.00616-2018
Year: 2018



Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

LATE-BREAKING ABSTRACT: Relationships between exhaled nitric oxide and lung function profiles in severe asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013


Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014


The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015


Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015